How to Analyse Bioactivity in Large Compound Libraries?
Dr. Steffen Renner, Investigator II, Molecular and Library Informatics at Novartis Pharma AG, speaks to Andrea Charles from Pharma IQ, about the current challenges relating to compound storage and retrieval and how are these issues affecting the success of HTS programs. In this interview, he also shares his insights on which compound libraries he thinks hold the most potential. [inlinead]
To continue reading this story get free access